Zepbound (Tirzepatide): This is the only dual agonist currently on the market, targeting both GLP-1 and GIP receptors
Its natural to have questions and concerns, and thats why open communication with your doctor is so important
The dual action makes tirzepatide particularly effective at reducing appetite without relying entirely on GLP-1's side effects, while also improving lipid profiles and metabolic markers
We assess your medical history, body composition, metabolic rate, and current medications to create a safe, customized plan that often includes FDA-approved GLP-1 agonist medications like Tirzepatide or Semaglutide
F.ShenL
Based on the findings, GLP-1 medications may benefit the cardiovascular and renal systems while also promoting weight loss, glycemic management, neurocognition, gut function, liver inflammation, alcohol use, and suicidal ideation